amitriptylin fairmed healthcare 44,2 mg filmtabletten
fairmed healthcare gmbh (8096063) - amitriptylinhydrochlorid - filmtablette - 44,2 mg - teil 1 - filmtablette; amitriptylinhydrochlorid (03958) 50 milligramm
amitriptylin-dura 10 mg
mylan dura gmbh (8006829) - amitriptylinhydrochlorid - filmtablette - teil 1 - filmtablette; amitriptylinhydrochlorid (03958) 11,32 milligramm
amitriptylin-dura 25 mg
mylan dura gmbh (8006829) - amitriptylinhydrochlorid - filmtablette - teil 1 - filmtablette; amitriptylinhydrochlorid (03958) 28,3 milligramm
amitriptylin mylan 75 mg hartkapseln, retardiert
mylan dura gmbh (8006829) - amitriptylinhydrochlorid - hartkapsel, retardiert - teil 1 - hartkapsel, retardiert; amitriptylinhydrochlorid (03958) 75 milligramm
amitriptylin mylan 25 mg hartkapseln, retardiert
mylan dura gmbh (8006829) - amitriptylinhydrochlorid - hartkapsel, retardiert - teil 1 - hartkapsel, retardiert; amitriptylinhydrochlorid (03958) 25 milligramm
amitriptylin micro labs 50 mg filmtabletten
micro labs gmbh (8144276) - amitriptylinhydrochlorid - filmtablette - teil 1 - filmtablette; amitriptylinhydrochlorid (03958) 56,5 milligramm
amitriptylin micro labs 25 mg filmtabletten
micro labs gmbh (8144276) - amitriptylinhydrochlorid - filmtablette - teil 1 - filmtablette; amitriptylinhydrochlorid (03958) 28,25 milligramm
amitriptylin micro labs 10 mg filmtabletten
micro labs gmbh (8144276) - amitriptylinhydrochlorid - filmtablette - teil 1 - filmtablette; amitriptylinhydrochlorid (03958) 11,3 milligramm
pirfenidone viatris
viatris limited - pirfenidone - idiopathic pulmonary fibrosis; lung diseases; respiratory tract diseases - immunsuppressiva - pirfenidone viatris is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (ipf).
dapagliflozin viatris
viatris limited - dapagliflozin - diabetes mellitus, type 2; heart failure, systolic; heart failure; renal insufficiency, chronic - drogen bei diabetes verwendet - type 2 diabetes mellitusdapagliflozin viatris is indicated in adults and children aged 10 years and above for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise- as monotherapy when metformin is considered inappropriate due to intolerance. - in addition to other medicinal products for the treatment of type 2 diabetes. for study results with respect to combination of therapies, effects on glycaemic control, cardiovascular and renal events, and the populations studied, see sections 4. 4, 4. 5 und 5. heart failuredapagliflozin viatris is indicated in adults for the treatment of symptomatic chronic heart failure with reduced ejection fraction. chronic kidney diseasedapagliflozin viatris is indicated in adults for the treatment of chronic kidney disease.